Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death

Christian Argueta(Karyopharm Therapeutics (United States)), Yosef Landesman(Karyopharm Therapeutics (United States))

Oncotarget

May 19, 2018

10.18632/oncotarget.25368

Cited by 45

Related Papers

Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death

|Oncotarget|2016|129

RKIP localizes to the nucleus through a bipartite nuclear localization signal and interaction with importin α to regulate mitotic progression

|Journal of Biological Chemistry|2023|4